You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復銳醫療科技(01696.HK)擬向多名管理層及員工授出逾400萬股受限制股份
阿思達克 09-10 08:54
復銳醫療科技(01696.HK)公布,董事會已於昨日(9日)批准採納2021年受限制股份單位計劃,惟須獲股東於股東特別大會批准,若計劃獲股東批准,年度授權可發行的新股份最多約2,210.8萬股,佔已發行股份總數約4.74%。 董事會又建議,向4名管理層授予合共約128.35萬份受限制股份單位,當中包括主席劉毅、首席執行官Lior Moshe DAYAN、首席財務官步國軍和副總裁Doron YANNAI。董事會亦批准建議向高級職員及資深員工和作為以色列僱員的參與者授出合共約273.1萬份受限制股份單位。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account